Multiple Sclerosis

Coming Soon

Blood Signals May Predict Multiple Sclerosis 7 Years Before Symptoms - ScienceAlert [Visit Site | Read More]

Zenas’ multiple sclerosis drug slows new brain lesions in mid-stage trial - Endpoints News [Visit Site | Read More]

Zenas' autoimmune drug prompts 95% reduction in new brain lesions in phase 2 MS study - Fierce Biotech [Visit Site | Read More]

Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis - Stock Titan [Visit Site | Read More]

CAR T-cell therapy obe-cel begins human trial for progressive MS - Multiple Sclerosis News Today [Visit Site | Read More]